Kite Pharma To Report Third Quarter 2016 Financial Results On November 9, 2016

Kite Pharma, Inc. (Nasdaq:KITE) today announced that it will report third quarter 2016 financial results on Wednesday, November 9, 2016, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 8:30 a.m. Pacific Time/11:30 a.m. Eastern Time.

Audio Webcast

The webcast will be made available on the Company's website at  www.kitepharma.com under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.

Dial-In Information

Live (U.S. / Canada): 1 (888) 771-4371Live (International): 1 (847) 585-4405Confirmation number: 43463182

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACTâ„¢) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit  www.kitepharma.com. Sign up to follow @KitePharma on Twitter at  www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161102005590/en/
Copyright Business Wire 2010

If you liked this article you might like

Juno, bluebird In Focus as Targets Following Gilead-Kite Aquisition

Faster Rebuild After Harvey; Micron Tech Breakout Would Be a Win: Best of Cramer

Getting Bullish on Gilead

How A Girl from India Came to Rule JPM's North America M&A Group

Stay Focused on the Green Lights: Cramer's 'Mad Money' Recap (Wed 8/30/17)